About 4 results found for searched term "AKT Kinase Inhibitor" (0.131 seconds)
Cat.No. | Name | Target |
---|---|---|
M14833 | AKT Kinase Inhibitor | Akt |
AKT Kinase Inhibitor is an Akt kinase inhibitor with anti-tumor activity. | ||
M27611 | PF-AKT400 | Akt |
AKT protein kinase inhibitor | ||
PF-AKT400 is a broadly selective, potent, ATP-competitive Akt inhibitor, displays 900-fold greater selectivity for PKBα (IC50=0.5 nM) than PKA (IC50=450 nM). | ||
M7690 | ML-9 | Autophagy |
ML-9 is a potent, selective Akt kinase inhibitor that inhibits myosin light chain kinase (MLCK) and stromal interaction molecule 1 (STIM1) activity. It acts on MLCK, PKA and PKC with Ki values of 4, 32 and 54 μM, respectively. In addition, ML-9 induces autophagy by stimulating the formation of autophagosomes and inhibiting their degradation. | ||
M28378 | Vevorisertib | Akt |
ARQ 751 | ||
Vevorisertib (ARQ 751) is an orally active, potent and selective pan-AKT serine/threonine kinase inhibitor against AKT1 (IC50=0.55 nM), AKT2 (IC50=0.81 nM), and AKT3 (IC50=1.31 nM). Vevorisertib, as a single agent or in combination with other anti-cancer agents, can be used for the research of solid tumors with PIK3CA / AKT / PTEN mutations. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.